Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Deleuran

Showing results (31-40 of 69) with videos related to

Pageof 7
Sort By:
Biochemical and Biophysical Research Communications|May 25, 1995
Interleukin-8 induces its own production in CD4+ T lymphocytes: a process regulated by interleukin 10B Gesser, B Deleuran, M Lund, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|October 20, 2020
Disease severity and trigger factors in Danish children with atopic dermatitis: a nationwide studyT Gerner, J H Haugaard, C Vestergaard, et al.
The British Journal of Dermatology|February 19, 2020
The European TREatment of ATopic eczema (TREAT) Registry Taskforce survey: prescribing practices in Europe for phototherapy and systemic therapy in adult patients with moderate-to-severe atopic eczemaF M Vermeulen, L A A Gerbens, J Schmitt, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|August 9, 2021
Effective clinical study recruitment of patients with atopic dermatitis through social mediaZ Ali, K M Joergensen, C Vestergaard, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 15, 1995
The delayed-type hypersensitivity reaction is dependent on IL-8. Inhibition of a tuberculin skin reaction by an anti-IL-8 monoclonal antibodyC G Larsen, M K Thomsen, B Gesser, et al.
Gut|April 6, 1999
A monoclonal anti-interleukin 8 antibody (WS-4) inhibits cytokine response and acute lung injury in experimental severe acute necrotising pancreatitis in rabbitsM O Osman, J U Kristensen, N O Jacobsen, et al.
The Journal of Dermatological Treatment|April 30, 2020
Dupilumab provides rapid and sustained improvement in SCORAD outcomes in adults with moderate-to-severe atopic dermatitis: combined results of four randomized phase 3 trialsS Barbarot, A Wollenberg, J I Silverberg, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|September 8, 2009
ETFAD/EADV eczema task force 2009 position paper on diagnosis and treatment of atopic dermatitisU Darsow, A Wollenberg, D Simon, et al.
The British Journal of Dermatology|February 6, 2019
Improvement of atopic dermatitis with dupilumab occurs equally well across different anatomical regions: data from phase III clinical trialsA Blauvelt, D Rosmarin, T Bieber, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|July 21, 2021
Position statement on the role of nurses in therapeutic patient education in atopic dermatitisK Thormann, H Aubert, S Barbarot, et al.
Pageof 7

Showing results (31-40 of 69) with videos related to

Sort By:
Pageof 7
Biochemical and Biophysical Research Communications|May 25, 1995
Interleukin-8 induces its own production in CD4+ T lymphocytes: a process regulated by interleukin 10B Gesser, B Deleuran, M Lund, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|October 20, 2020
Disease severity and trigger factors in Danish children with atopic dermatitis: a nationwide studyT Gerner, J H Haugaard, C Vestergaard, et al.
The British Journal of Dermatology|February 19, 2020
The European TREatment of ATopic eczema (TREAT) Registry Taskforce survey: prescribing practices in Europe for phototherapy and systemic therapy in adult patients with moderate-to-severe atopic eczemaF M Vermeulen, L A A Gerbens, J Schmitt, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|August 9, 2021
Effective clinical study recruitment of patients with atopic dermatitis through social mediaZ Ali, K M Joergensen, C Vestergaard, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 15, 1995
The delayed-type hypersensitivity reaction is dependent on IL-8. Inhibition of a tuberculin skin reaction by an anti-IL-8 monoclonal antibodyC G Larsen, M K Thomsen, B Gesser, et al.
Gut|April 6, 1999
A monoclonal anti-interleukin 8 antibody (WS-4) inhibits cytokine response and acute lung injury in experimental severe acute necrotising pancreatitis in rabbitsM O Osman, J U Kristensen, N O Jacobsen, et al.
The Journal of Dermatological Treatment|April 30, 2020
Dupilumab provides rapid and sustained improvement in SCORAD outcomes in adults with moderate-to-severe atopic dermatitis: combined results of four randomized phase 3 trialsS Barbarot, A Wollenberg, J I Silverberg, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|September 8, 2009
ETFAD/EADV eczema task force 2009 position paper on diagnosis and treatment of atopic dermatitisU Darsow, A Wollenberg, D Simon, et al.
The British Journal of Dermatology|February 6, 2019
Improvement of atopic dermatitis with dupilumab occurs equally well across different anatomical regions: data from phase III clinical trialsA Blauvelt, D Rosmarin, T Bieber, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|July 21, 2021
Position statement on the role of nurses in therapeutic patient education in atopic dermatitisK Thormann, H Aubert, S Barbarot, et al.
Pageof 7